Evolent Health earnings were -$507.7M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest EVH earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$23.6M, down 16.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EVH reported annual earnings of -$579.4M, with 520% growth.
On EVH's earnings call on Nov 5, 2026, Evolent Health (NYSE: EVH) reported Q3 2026 earnings per share (EPS) of -$0.21, up 12.5% year over year. Total EVH earnings for the quarter were -$23.57 million. In the same quarter last year, Evolent Health's earnings per share (EPS) was -$0.24.
As of the last Evolent Health earnings report, Evolent Health is currently losing money. Evolent Health's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$507.69 million, a 296.08% increase year over year.
What was EVH's earnings growth in the past year?
As of Evolent Health's earnings date in Nov 5, 2026, Evolent Health's earnings has grown year over year. EVH earnings in the past year totalled -$507.69 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.